$0.54
-0.02 (-4.16%)
Performance
1D
-15.26%
1W
-7.89%
1M
-43.35%
3M
-64.44%
6M
-69.49%
1Y
-88.55%
YTD
-88.50%
Open$0.55
Previous Close$0.56
Day High$0.57
Day Low$0.53
52W High$5.93
52W Low$0.53
Volume—
Avg Volume811.3K
Market Cap37.16M
P/E Ratio—
EPS$-0.38
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.05
Below
SMA 200
$2.17
Below
RSI (14)
46.7
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+7,941.0% upside
Current
$0.54
$0.54
Target
$43.18
$43.18
$31.72
$43.18 avg
$59.84
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 34.78M | 32.14M | 39.05M |
| Net Income | 5.77M | 7.01M | 8.10M |
| Profit Margin | 16.6% | 21.8% | 20.7% |
| EBITDA | 11.08M | 11.55M | 13.91M |
| Free Cash Flow | 4.11M | 3.56M | 7.02M |
| Rev Growth | +3.0% | +6.5% | +17.8% |
| Debt/Equity | 0.16 | 0.15 | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |